Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Non-Current Liabilities (2021 - 2024)

Skinvisible (SKVI) has disclosed Total Non-Current Liabilities for 4 consecutive years, with $9.4 million as the latest value for Q4 2024.

  • Quarterly Total Non-Current Liabilities rose 2.09% to $9.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2024, up 2.09% year-over-year, with the annual reading at $9.4 million for FY2024, 2.09% up from the prior year.
  • Total Non-Current Liabilities hit $9.4 million in Q4 2024 for Skinvisible, down from $10.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $10.0 million in Q3 2024 to a low of $5.0 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $7.5 million across 4 years, with a median of $7.6 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 44.2% in 2023 and later rose 2.09% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $5.6 million in 2021, then rose by 22.8% to $6.9 million in 2022, then surged by 33.37% to $9.2 million in 2023, then rose by 2.09% to $9.4 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for SKVI at $9.4 million in Q4 2024, $10.0 million in Q3 2024, and $9.7 million in Q2 2024.